drugset / Trial / NCT02306564

Effect of Cabergoline on Endometrial Vascularity During IntraCytoplasmic Sperm Injection

NCT02306564

Phase 2/3 Unknown 150 enrolled Kasr El Aini Hospital
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

The purpose of this study is to determine the effect of giving cabergoline to patients at risk of OHSS (ovarian hyperstimulation syndrome) after ovum pick up, on endometrial vascularity and it's effect on pregnancy outcome

Timeline

Start
2014-12
Primary completion
2017-11
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cabergoline Small molecule 0.5 mg

Indications